FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/11/2024
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Yue (Robert) Xu Apex Attorneys at Law, LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Injectable pharmaceuticals for treatment of anaphylactic reactions; Metallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Vaccines; Antibiotic tablets; Allergy tablets; Mineral, vitamin, or nutritionally enhanced water for medical purposes; Medicated water for the treatment of illnesses attributed to insufficient cellular energy; Medicated water for the treatment of allergies, cough, cold, flu, headache, pain; Medicated water for the treatment of infectious diseases, skin diseases and conditions, and internal diseases and conditions; Medicated water for the treatment of pain, nausea and muscle spasms; Medicated water-based solutions in the nature of serums for treating skin infections and skin conditions; Medicated water for the treatment of gastrointestinal disorders; Demineralised water for medical purposes; Antibiotic ointments; Anti-inflammatory ointments; Medicated ointments for treating dermatological conditions; Chinese medicine nostrum in the nature of natural remedy preparation, namely, medicinal herbs; Diagnostic kits comprised of medical diagnostic reagents for testing of bodily fluids for use in disease testing, health monitoring, and predictive and preventive medicine in the fields of detecting immune system and respiratory system diseases, cancer, infectious diseases, inflammatory disorders, and oncological disorders; Purified biochemical medical diagnostic reagents, namely, protein arrays for medical diagnosis purposes, enzymes for medical purposes, and fluorescent surgical dyes; Biological preparations for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; Biochemical drugs in the nature of biochemical drug delivery systems comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents for the treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; Diagnostic preparations for medical purposes; Chemical-pharmaceutical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory system; Chemical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory systems; Preparations for detecting mutation in prion genes for medical purposes; Chemical reagents for medical or veterinary purposes; Reagents for medical use; Reagents for use in medical genetic testing; Medical diagnostic reagents; Enzyme preparations for medical purposes; Diagnostic biomarker reagents for medical purposes; Rat poison; Medical dressings; Materials for artificial teeth; Diapers for pets; Reagent paper for medical purposes; Chemical preparations for the diagnosis of pregnancy; Preparations for detecting genetic predispositions for medical purposes; Immunoassay reagents for medical use; Genetic identity tests comprised of reagents for medical purposes; Cultures of microorganisms for medical or veterinary use; Diagnostic preparations for veterinary purposes
Classe 9
Downloadable computer operating programs; Recorded computer operating software; Downloadable software application for mobile phones, namely, downloadable software for use in operating polymerase chain reaction (PCR) instruments; Downloadable software application for mobile phones, namely, downloadable software for DNA and gene analysis; Data processing apparatus; Biometric scanners; Chemistry apparatus and instruments, namely, liquid test tubes and containers in the nature of laboratory glassware beakers, solvent reservoirs, and chromatography columns for laboratory use; Chromatography apparatus for laboratory use; MRI apparatus, not for medical purposes; Automatic ion exchange chromatography apparatus for laboratory use; Polymerase chain reaction (PCR) instruments for use in scientific research, namely, laboratory apparatus and instruments for amplifying DNA using polymerase chain reaction, not for medical purposes; DNA chips; Electronic devices for analyzing genome information for laboratory use; Nucleic acid sequencers for scientific purposes; Laboratory devices for detecting genetic sequences; Bio-chips for research or scientific purposes
Classe 10
Apparatus for DNA and RNA testing for medical purposes; Blood testing apparatus; Probes for medical purposes; analysers for bacterial identification for medical purposes; Diagnostic apparatus for medical purposes in the nature of medical diagnostic imaging apparatus for use with computer displays and computer monitors for use with recorded computer operating software and recorded smartphone operating software, all sold as a unit; Medical equipment, namely, devices for bioanalysis of pathogens in the nature of reagent cartridges for sample preparation, nucleic acid purification, nucleic acid amplification and electrochemical detection for medical diagnostic purposes; Surgical apparatus and instruments; Genetic testing apparatus for medical purposes; Apparatus for use in medical analysis, namely, apparatus for blood analysis, body composition analyzers, apparatus for analyzing and detecting bacteria and viruses, apparatus for analyzing and detecting DNA and RNA, apparatus for analyzing and detecting genes, apparatus for analyzing blood vessels, apparatus for cavitation detecting, and apparatus for imaging analysis; Body composition analyzers for medical purposes; Radiotherapy apparatus; Physiotherapy apparatus, namely, body rehabilitation apparatus for medical use; Lasers for medical purposes; Orthopaedic belts; Orthopaedic bandages; Orthopaedic footwear; Suture materials
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
FINAL DECISION TRANSACTION PROCESSED BY IB
09/11/2024
FINAL DISPOSITION NOTICE SENT TO IB
17/10/2024
FINAL DISPOSITION PROCESSED
17/10/2024
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/07/2024
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/04/2024
REGISTERED-PRINCIPAL REGISTER
02/04/2024
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/01/2024
PUBLISHED FOR OPPOSITION
16/01/2024
NOTIFICATION PROCESSED BY IB
13/01/2024
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/12/2023
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
27/12/2023
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/12/2023
APPROVED FOR PUB - PRINCIPAL REGISTER
14/12/2023
EXAMINER'S AMENDMENT ENTERED
14/12/2023
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
14/12/2023
EXAMINERS AMENDMENT E-MAILED
14/12/2023
EXAMINERS AMENDMENT -WRITTEN
14/12/2023
TEAS/EMAIL CORRESPONDENCE ENTERED
20/11/2023
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/11/2023
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/11/2023
REFUSAL PROCESSED BY IB
13/09/2023
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/08/2023
REFUSAL PROCESSED BY MPU
21/08/2023
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
27/07/2023
NON-FINAL ACTION WRITTEN
26/07/2023
ASSIGNED TO EXAMINER
24/07/2023
APPLICATION FILING RECEIPT MAILED
31/01/2023
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/01/2023
LIMITATION FROM ORIGINAL APPLICATION ENTERED
23/01/2023
SN ASSIGNED FOR SECT 66A APPL FROM IB
19/01/2023
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.